2-({[6-oxo-1-(prop-2-en-1-yl)-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl]sulfanyl}methyl)benzonitrile

Catalog No. :
ACSDFO042
CAS No. :
866143-17-1
Molecular Formula :
C16H12F3N3OS
Molecular Weight :
351.35

IUPAC Name:2-(((1-allyl-6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl)thio)methyl)benzonitrile

2-({[6-oxo-1-(prop-2-en-1-yl)-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl]sulfanyl}methyl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-({[6-oxo-1-(prop-2-en-1-yl)-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl]sulfanyl}methyl)benzonitrile
IUPAC Name2-(((1-allyl-6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl)thio)methyl)benzonitrile
MDL No.MFCD04126212
Molecular FormulaC16H12F3N3OS
Molecular Weight351.35
SMILESN#CC1=CC=CC=C1CSC2=NC(C(F)(F)F)=CC(N2CC=C)=O
InChI KeySWGRJLREGIQKME-UHFFFAOYSA-N
Synonym2-({[1-Allyl-6-oxo-4-(trifluoromethyl)-1,6-dihydro-2-pyrimidinyl]sulfanyl}methyl)benzenecarbon;Benzonitrile, 2-[[[1,6-dihydro-6-oxo-1-(2-propen-1-yl)-4-(trifluoromethyl)-2-pyrimidinyl]thio]methyl]-;2-(((1-Allyl-6-oxo-4-(trifluoromethyl)-1,6-dihydropyrimidin-2-yl)thio)methyl)benzonitrile
CAS No.866143-17-1

Synthetic Route by SureRoute

1. ACSDFO042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDFO042 route product structure diagram
    ACSDFO042866143-17-1
Inquiry

2. ACSDFO042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDFO042 route product structure diagram
    ACSDFO042866143-17-1
Inquiry

Comments (0)